MEMORIAL HERMANN SUGARLAND — History
CCN 450848 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$298M
Latest Revenue (FY2022)
+13.5%
Revenue CAGR (3yr)
11.4%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $232M | $288M | $298M | +3.6% | +13.5% |
| Operating Expenses | $202M | $238M | $264M | +11.2% | +14.4% |
| Operating Margin | 12.8% | 17.4% | 11.4% | -34.7% | -5.7% |
| Net Income | $30M | $50M | $34M | -32.3% | +7.0% |
| Licensed Beds | 205 | 175 | 205 | +17.1% | +0.0% |
| Total Patient Days | 37,655 | 42,473 | 42,664 | +0.4% | +6.4% |
| Medicare Day % | 19% | 17% | 18% | +2.6% | -2.5% |
| Medicaid Day % | 11% | 4% | 11% | +164.8% | -0.9% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +28.8% ($232M → $298M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+13.5%
This Hospital
+7.6%
State Avg
Latest Margin
11.4%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $332M | 10.7% |
| FY2024 (proj) | $365M | 10.0% |
| FY2025 (proj) | $398M | 9.2% |